Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

Social Affairs Committee confirms Safatle, Cerqueira, and Cardoso's names, in a moment of important reforms at the agency

Social Affairs Committee to analyze four names for leadership positions in health agencies

With direct application to the skin, CBD cream offers localized therapeutic effects, being a safe alternative for muscle pain, inflammation, and dermatological problems

Shipping cannabis products via the Post Office is still prohibited, but companies are finding specialized solutions to meet the growing demand of the medicinal market

Cases of accidental cannabis ingestion by children are increasing and require quick attention and specific care

General coordinator details the efforts made by the public agency

Experts discuss the importance of integrativity in cannabinoid dentistry and the legal certainty of the process

Pharmaceutical Assistance Coordination evaluates proposals in a public session. The announcement of the winning company is expected in 2023, subject to appeals and disqualifications.

Understand the step-by-step process to acquire plant derivatives for medicinal purposes

Dib was one of the main figures behind the regulation of medicinal cannabis use in Brazil and tomorrow he will clarify doubts about the current Anvisa legislation and discuss the agency's perspectives for the coming years regarding the plant

The business sector sees great potential for business from the permission to cultivate and process cannabis for industrial purposes, creating a completely new industry with various players.

In Brazil alone, the medicinal market is expected to reach over R$ 600 million in 2023, according to a report by the data intelligence company Kaya Mind

On the anniversary of the National Health Surveillance Agency (Anvisa), learn about the evolution of the medicinal use of cannabis over the 23 years since the agency was created

Check out the confirmed names: Beatriz Marti Emygdio, Filipe Campos, Tarso Araujo, and João Paulo Silvério Perfeito will be among the specialists participating in the event in São Paulo

Even with evident clinical improvement, treatment with vaporized cannabis flowers is still limited by legal and bureaucratic barriers

Patients who rely on medicinal cannabis face legal battles and, in many cases, imprisonment. Understand the challenges of access, the legal impacts, and the stories of those fighting for the right to treatment in Brazil.

In another column for Sechat, The Green Hub's Head of Business Marcelo De Vita Grecco evaluates the current regulatory scenario of cannabis in Brazil and suggests the possibility of a plan B, at a time when the focus is on the resumption of the legislative process.

The intention of the state foundation, maintained by the Federal Government, stands out due to the fact that, currently, the cultivation of the Cannabis sativa plant is prohibited by Brazilian legislation